The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer

and the Hereditary Breast Cancer Clinical Study Group

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The objective of this study was to estimate the lifetime risk of breast cancer in women with a BRCA1 or BRCA2 mutation with and without at least 1 first-degree relative with breast cancer. A total of 2835 women with a BRCA1 or BRCA2 mutation were followed. Age- and gene-specific breast cancer rates were calculated. The relative risks of breast cancer for subjects with a family history of breast cancer, compared to no family history were calculated. The mean age at baseline was 41.1 years, and they were followed for a mean of 6.0 years. The estimated penetrance of breast cancer to age 80 years was 60.8% for BRCA1 and 63.1% for BRCA2. For all BRCA carriers, the penetrance of breast cancer to age 80 for those with no first-degree relative with breast cancer was 60.4% and 63.3% for those with at least 1 first-degree relative with breast cancer. The risk of breast cancer for BRCA carriers with no first-degree relative with breast cancer is substantial, and as a result, clinical management for these women should be the same as those for women with an affected relative.

Original languageEnglish (US)
Pages (from-to)1063-1068
Number of pages6
JournalClinical Genetics
Volume93
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Breast Neoplasms
Mutation
Penetrance
Genes

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer. / and the Hereditary Breast Cancer Clinical Study Group.

In: Clinical Genetics, Vol. 93, No. 5, 01.05.2018, p. 1063-1068.

Research output: Contribution to journalArticle

and the Hereditary Breast Cancer Clinical Study Group. / The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer. In: Clinical Genetics. 2018 ; Vol. 93, No. 5. pp. 1063-1068.
@article{a7672b5c271a4760b19514d9ca98168a,
title = "The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer",
abstract = "The objective of this study was to estimate the lifetime risk of breast cancer in women with a BRCA1 or BRCA2 mutation with and without at least 1 first-degree relative with breast cancer. A total of 2835 women with a BRCA1 or BRCA2 mutation were followed. Age- and gene-specific breast cancer rates were calculated. The relative risks of breast cancer for subjects with a family history of breast cancer, compared to no family history were calculated. The mean age at baseline was 41.1 years, and they were followed for a mean of 6.0 years. The estimated penetrance of breast cancer to age 80 years was 60.8{\%} for BRCA1 and 63.1{\%} for BRCA2. For all BRCA carriers, the penetrance of breast cancer to age 80 for those with no first-degree relative with breast cancer was 60.4{\%} and 63.3{\%} for those with at least 1 first-degree relative with breast cancer. The risk of breast cancer for BRCA carriers with no first-degree relative with breast cancer is substantial, and as a result, clinical management for these women should be the same as those for women with an affected relative.",
author = "{and the Hereditary Breast Cancer Clinical Study Group} and Metcalfe, {K. A.} and J. Lubinski and J. Gronwald and T. Huzarski and J. McCuaig and Lynch, {Henry T.} and B. Karlan and Foulkes, {W. D.} and Singer, {C. F.} and Neuhausen, {S. L.} and L. Senter and A. Eisen and P. Sun and Narod, {S. A.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1111/cge.13191",
language = "English (US)",
volume = "93",
pages = "1063--1068",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer

AU - and the Hereditary Breast Cancer Clinical Study Group

AU - Metcalfe, K. A.

AU - Lubinski, J.

AU - Gronwald, J.

AU - Huzarski, T.

AU - McCuaig, J.

AU - Lynch, Henry T.

AU - Karlan, B.

AU - Foulkes, W. D.

AU - Singer, C. F.

AU - Neuhausen, S. L.

AU - Senter, L.

AU - Eisen, A.

AU - Sun, P.

AU - Narod, S. A.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - The objective of this study was to estimate the lifetime risk of breast cancer in women with a BRCA1 or BRCA2 mutation with and without at least 1 first-degree relative with breast cancer. A total of 2835 women with a BRCA1 or BRCA2 mutation were followed. Age- and gene-specific breast cancer rates were calculated. The relative risks of breast cancer for subjects with a family history of breast cancer, compared to no family history were calculated. The mean age at baseline was 41.1 years, and they were followed for a mean of 6.0 years. The estimated penetrance of breast cancer to age 80 years was 60.8% for BRCA1 and 63.1% for BRCA2. For all BRCA carriers, the penetrance of breast cancer to age 80 for those with no first-degree relative with breast cancer was 60.4% and 63.3% for those with at least 1 first-degree relative with breast cancer. The risk of breast cancer for BRCA carriers with no first-degree relative with breast cancer is substantial, and as a result, clinical management for these women should be the same as those for women with an affected relative.

AB - The objective of this study was to estimate the lifetime risk of breast cancer in women with a BRCA1 or BRCA2 mutation with and without at least 1 first-degree relative with breast cancer. A total of 2835 women with a BRCA1 or BRCA2 mutation were followed. Age- and gene-specific breast cancer rates were calculated. The relative risks of breast cancer for subjects with a family history of breast cancer, compared to no family history were calculated. The mean age at baseline was 41.1 years, and they were followed for a mean of 6.0 years. The estimated penetrance of breast cancer to age 80 years was 60.8% for BRCA1 and 63.1% for BRCA2. For all BRCA carriers, the penetrance of breast cancer to age 80 for those with no first-degree relative with breast cancer was 60.4% and 63.3% for those with at least 1 first-degree relative with breast cancer. The risk of breast cancer for BRCA carriers with no first-degree relative with breast cancer is substantial, and as a result, clinical management for these women should be the same as those for women with an affected relative.

UR - http://www.scopus.com/inward/record.url?scp=85044197589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044197589&partnerID=8YFLogxK

U2 - 10.1111/cge.13191

DO - 10.1111/cge.13191

M3 - Article

VL - 93

SP - 1063

EP - 1068

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 5

ER -